APA (7th ed.) Citation

Mellitus, E. t. D. (2012). Expert committee on novel DPP-4 inhibitor TRADJENTA (linagliptin) in treatment of type 2 diabetes mellitus. Endocrinology Research Centre.

Chicago Style (17th ed.) Citation

Mellitus, Editorial team Diabetes. Expert Committee on Novel DPP-4 Inhibitor TRADJENTA (linagliptin) in Treatment of Type 2 Diabetes Mellitus. Endocrinology Research Centre, 2012.

MLA (8th ed.) Citation

Mellitus, Editorial team Diabetes. Expert Committee on Novel DPP-4 Inhibitor TRADJENTA (linagliptin) in Treatment of Type 2 Diabetes Mellitus. Endocrinology Research Centre, 2012.

Warning: These citations may not always be 100% accurate.